Cuflift-LS Syrup contains combination of Levosalbutamol (bronchodilator), Ambroxol (mucolytic agent) and Guaifenesin (expectorant). It is used for the treatment of productive cough associated with bronchospasm in conditions such as bronchitis and bronchial asthma, COPD, emphysema as well as all conditions associated with tenacious mucus, wheezing and chest congestion.
Each 5 ml of syrup contains Ambroxol Hydrochloride 30 mg, Guaiphenesin 50 mg & Levosalbutamol 1 mg
Code: NHPM93